Vancomycin-associated acute kidney injury: a cross-sectional study from a single center in china

  • At: 2017 FIP Congress in Seoul (South Korea)
  • Type: Poster
  • By: ZHOU, Ying (Peking University First Hospital, Department of Pharmacy, Beijing, China)
  • Co-author(s): Ying ZHOU: Department of Pharmacy, Peking University First Hospital, Beijing, China
    Li YANG: Department of Nephrology, Peking University First Hospital, Beijing, China
    Yimin CUI: Department of Pharmacy, Peking University First Hospital, Beijing, China
  • Abstract:

    Background

    AKI is still the main serious ADR experienced by patients receiving VAN treatment. Some studies have reported AKI incidences of up to 40%.it is clinically important to confirm the risk factors for VA-AKI to help guide clinicians toward the more rational administration of VAN.

    Purpose

    The objective of this study was to investigate the..

  • The access to the whole abstract and the presentation file is available to FIP members and to congress participants of that specific congress. Please login